Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Nov 9, 2006

Bayer CropScience to Enhance Canola Yields with Senesco Technologies´ Gene Technology

  • Bayer CropScience exclusively licensed the rights to Senesco Technologies’ gene technology for use in Brassica oilseeds. “Senesco has shown that the seed yield of Canola can be significantly increased by modulating the expression of its proprietary genes,” says Michiel van Lookeren Campagne, Ph.D., head of research at BioScience, a business operations unit of Bayer CropScience.

    Bayer CropScience will thus use this technology to enhance Canola yields in its InVigor® and future hybrid’s business on a global basis. In return, Senesco will receive success-bound development milestones and commercialization payments.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »